Carregant...
Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
People with type 2 diabetes are at increased risk of bladder cancer. Pioglitazone is said to increase it further, although published evidence is mixed. We conducted a meta-analysis to determine if any link between the use of pioglitazone and an increased risk of bladder cancer can be found. A compre...
Guardat en:
| Publicat a: | Diabetes Ther |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Healthcare
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5544610/ https://ncbi.nlm.nih.gov/pubmed/28623552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0273-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|